FDA Adverse Event Injury Summary report: N

VALIANT THORACIC

MDR report key: 3052455 · Received April 11, 2013

Report

Report Number
2953200-2013-00658
Event Type
Injury
Date Received
April 11, 2013
Date of Event
July 15, 2009
Report Date
March 15, 2013
Manufacturer
MEDTRONIC CARDIOVASCULAR SANTA ROSA
Product Code
MIH
PMA / PMN Number
P100040
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). RESULTS: ENDOLEAK. TYPE V ENDOLEAK. CONCLUSION: TYPE V ENDOLEAK.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED. IT WAS REPORTED THAT THE PREVIOUSLY REPORTED TYPE V ENDOLEAK RESOLVED WITHOUT TREATMENT. THE PHYSICIAN ASSESSED THIS EVENT AS NOT PROCEDURE RELATED. THE DEVICE RELATION REMAINS UNKNOWN.

Description of Event or Problem · 1

A VALIANT THORACIC STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC ANEURYSM APPROXIMATELY 45 MONTHS AGO. ANEURYSM AND VESSEL MORPHOLOGY FROM THE TIME OF IMPLANT WERE NOT REPORTED. IT WAS REPORTED THAT TWO YEARS POST IMPLANT, A TYPE V ENDOLEAK WAS IDENTIFIED AND NO INTERVENTION WAS PERFORMED. THE INVESTIGATOR ASSESSED THIS EVENT AS NOT PROCEDURE RELATED AND DEVICE RELATIONSHIP WAS NOT REPORTED. ADDITIONAL INFORMATION WAS RECEIVED RECENTLY WHERE IT WAS REPORTED THAT THE ANEURYSM DIAMETER INCREASED 10 MM OVER A 12 MONTH PERIOD AND THIS WAS DUE TO THE TYPE V ENDOLEAK WHICH WAS PREVIOUSLY REPORTED. THE ANEURYSM EXPANSION WAS IN ZONE 3 AND 4 OF THE THORACIC AORTA. THE DEVICE AND PROCEDURE RELATION ARE UNKNOWN. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE. PLEASE NOTE THAT THIS MODEL NUMBER TF3636C150XC IS NOT APPROVED IN THE UNITED STATES; HOWEVER, IT IS SIMILAR TO THE VAMF3636C150TE WHICH IS APPROVED IN THE UNITED STATES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
155693 VALIANT THORACIC SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH MEDTRONIC CARDIOVASCULAR SANTA ROSA V00285424

Patients

Seq Age Sex Outcome Treatment
1 00061 YR